Gaush Meditech Past Earnings Performance

Past criteria checks 0/6

Gaush Meditech's earnings have been declining at an average annual rate of -46.5%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 6.1% per year.

Key information

-46.5%

Earnings growth rate

-44.2%

EPS growth rate

Medical Equipment Industry Growth13.7%
Revenue growth rate6.1%
Return on equity-11.6%
Net Margin-13.6%
Next Earnings Update25 Mar 2024

Recent past performance updates

Recent updates

Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)

Dec 07
Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)

A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)

Aug 08
A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)

Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry

Jun 01
Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry

Revenue & Expenses Breakdown
Beta

How Gaush Meditech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2407 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 231,377-18735745
31 Mar 231,315-26834643
31 Dec 221,254-35033441
30 Sep 221,276-27833639
30 Jun 221,298-20733837
31 Mar 221,298-19932930
31 Dec 211,298-19032124
31 Dec 20962992513
31 Dec 191,107-372793

Quality Earnings: 2407 is currently unprofitable.

Growing Profit Margin: 2407 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2407 is unprofitable, and losses have increased over the past 5 years at a rate of 46.5% per year.

Accelerating Growth: Unable to compare 2407's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2407 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.3%).


Return on Equity

High ROE: 2407 has a negative Return on Equity (-11.56%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.